Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Q3 Interim Management Statement

3 Feb 2015 07:00

RNS Number : 8342D
Creston PLC
03 February 2015
 

 

Creston plc

Interim Management Statement

 

Creston plc ('Creston' or the 'Group') (LSE: CRE), the marketing communications group, today announces its interim management statement for 1 October 2014 to date.

 

Following an encouraging H1 in which revenues grew 5 per cent, growth in the three months to 31 December 2014 was lower, with Group revenue up 1 per cent on the prior period giving rise to year-on-year growth of 3 per cent for the year-to-date (4 per cent on a constant currency basis).

 

Our Communications & Insight division continued to perform well. Our third quarter revenue performance was as a result of some client budget cuts and project delays within the UK health business, which will also affect the Group's final quarter revenue. As a consequence the Board expects full year Group revenue growth, but for it to be lower than expectations.

 

Operating costs have been reduced and, based on current trading, the Board expects Group Headline PBT for the full year to be broadly in line with market expectations. With a lower effective tax rate than anticipated, Headline Diluted EPS is expected to be in line with market expectations.

 

New Business and Strategy

 

The Group continues to achieve new business success, winning high profile brands such as Mclaren and Superfast Broadband, with post period wins including Vue, Barilla and La Roche-Posay. It has also expanded its work for existing clients such as Sony Mobile and Novartis.

 

The repositioning of Creston as a full service agency group of specialists, following the launch in November 2014 of Creston Unlimited and the Unlimited rebrand of Group companies, has been well received by clients, intermediaries and prospective partners. There has been good external interest in our expanded Creston Unlimited offer with an encouraging level of multi-agency new business pitches. Creston Unlimited is also working well with its new international partner, Serviceplan, and together we are pitching for a growing number of international opportunities.

 

As previously acknowledged, digital work by its nature can lead to variability in annual income over the course of a client relationship. The Board therefore continues to pursue its strategy of broadening the Group's offer from pure marketing execution services to include consultancy led marketing advice. This should lead to greater pipeline visibility and more long term retained instructions.

 

Outlook

 

While the marketing services sector remains vulnerable to the impact of macro-economic events and their potential to affect our clients' budgets in the FY15 final quarter, the Board is confident that the Group, with its new management, strengthened Creston Unlimited offer and first-rate blue chip client relationships, is well-placed to deliver long-term growth.

 

-ends-

 

 

 

 

For further information please contact:

 

Creston plc

+ 44 (0)20 7930 9757

Barrie Brien, Group Chief Executive

 

Kathryn Herrick, Chief Financial Officer

 

 

 

Bell Pottinger

+44 (0)20 3772 2491

Elly Williamson/Lucy Stewart

 

 

 

About Creston plc

Creston plc (LSE: CRE), incorporating the Creston Unlimited group offer, is a marketing communications group delivering a range of digital technology-based marketing solutions to blue-chip global clients. Encompassing consultants and discipline experts from across the industry and beyond, Creston Unlimited unlocks the power of creative collaboration to realise the opportunities that exist for brands and businesses in today's rapidly evolving world. www.creston.com / www.creston-unlimited.com  

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSPKBDQOBKDBBK
Date   Source Headline
16th May 20254:48 pmRNSDirector/PDMR Shareholding
14th May 20255:57 pmRNSResult of AGM
14th May 20255:51 pmRNSDirector/PDMR Shareholding
14th May 20257:00 amRNSCEO appointment and Directorate Changes
14th May 20257:00 amRNSTrading Update for Q1 2025
6th May 20257:00 amRNSNotice of Q1 2025 Trading Update
22nd Apr 20257:00 amRNSAppointment of Interim CUO
10th Apr 20255:07 pmRNSNotice of AGM
10th Apr 20254:40 pmRNSHolding(s) in Company
10th Apr 20254:39 pmRNSPurchase of Shares by Employee Benefit Trust
9th Apr 20255:49 pmRNSDirector/PDMR Shareholding
9th Apr 20255:33 pmRNSPurchase of Shares by Employee Benefit Trust
8th Apr 20252:59 pmRNSPurchase of Shares by Employee Benefit Trust
7th Apr 20251:28 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20255:27 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20251:21 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:22 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:08 pmRNSPurchase of Shares by Employee Benefit Trust
2nd Apr 20255:10 pmRNSHolding(s) in Company
2nd Apr 20255:09 pmRNSPurchase of Shares by Employee Benefit Trust
1st Apr 20256:20 pmRNSDirector/PDMR Shareholding
31st Mar 20257:00 amRNSCEO Retirement
26th Mar 20255:54 pmRNSDirector/PDMR Shareholding
26th Mar 20255:51 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:45 pmRNSDirector/PDMR Shareholding
26th Mar 20255:44 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
14th Mar 202512:20 pmRNSNotification of Major Holdings
14th Mar 202512:19 pmRNSNotification of Major Holdings
11th Mar 202512:22 pmRNSNotification of Major Holdings
27th Feb 20258:00 amRNSPublication of 2024 Annual Report and Accounts
25th Feb 20257:00 amRNSDirector/PDMR Shareholding
24th Feb 20257:00 amRNSDirector/PDMR Shareholding
19th Feb 20257:00 amRNSPreliminary results for the year ended 31/12/24
30th Jan 20257:00 amRNSNotice of Results
18th Dec 20247:00 amRNSComment on AM Best ratings outlook
15th Nov 20247:00 amRNSDirector/PDMR Shareholding
13th Nov 20245:35 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20247:00 amRNSDirector/PDMR Shareholding - Amendment
7th Nov 20244:26 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSTrading Statement
23rd Oct 20243:02 pmRNSNotice of Results
4th Sep 20243:36 pmRNSDirector/PDMR Shareholding
14th Aug 20247:00 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSInterim Results for the six months to 30/06/2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.